🟢 Senti Biosciences is trading 9.74% up in pre-market with no company-specific catalyst identified

Senti Biosciences is trading at $0.25, up 9.74% in pre-market, with no company-specific news found to explain the move.

• On October 15, shareholders approved a merger agreement and a possible 1-for-20 to 1-for-50 reverse split; available evidence does not establish that the votes caused this morning’s gain.
• The biotech sector was weaker, with XBI reported down 3.65%, which does not clearly explain the stock’s rise.